|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/20 | |
| A61K 31/35 | |||
| A61P 9/00 |
| (11) | Patento numeris | 1885724 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06763351.1 |
| Europos patento paraiškos padavimo data | 2006-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-02-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-06-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2006/062696 |
| Data | 2006-05-30 |
| (87) | Numeris | WO 2006/128853 |
| Data | 2006-12-07 |
| (30) | Numeris | Data | Šalis |
| 923052005 | 2005-05-31 | CH |
| (72) |
HEROLD, Peter, CH
MAH, Robert, CH
TSCHINKE, Vincenzo, CH
STOJANOVIC, Aleksandar, CH
MARTI, Christiane, CH
JOTTERAND, Nathalie, CH
SCHUMACHER, Christoph, CH
QUIRMBACH, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | HETEROCYCLIC SPIRO-COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS |
| HETEROCYCLIC SPIRO-COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS |